# Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

> **NCT00842829** · PHASE4 · TERMINATED · sponsor: **Cephalon** · enrollment: 330 (actual)

## Conditions studied

- Cancer Pain
- Breakthrough Pain

## Interventions

- **DRUG:** Fentanyl Buccal Tablet (FBT)

## Key facts

- **NCT ID:** NCT00842829
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 330 (ACTUAL)
- **Why stopped:** Recruitment stopped at the end of the recruitment timeframe
- **Last updated:** 2012-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842829, "Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00842829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*